Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

lynparza

Lynparza extends progression-free survival in gBRCAm metastatic pancreatic cancer

February 26, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, Pancreatic cancer, lynparza, pharma

AstraZeneca and MSD have lifted the curtain on new Phase 3 data for Lynparza (olaparib), confirming that the drug generated …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …

News
040424_026_avonmouth

Avara Avlon falls into administration putting 270 Bristol jobs at risk

February 21, 2019
Manufacturing and Production AstraZeneca, Avara Avlon, Bristol, CDMO, Jobs, UK, manufacturing

Bristol-based pharma firm Avara Avlon Pharmaceuticals has fallen into administration putting the jobs of all 270 of its staff at …

News

AstraZeneca to retire MedImmune brand amid restructuring

February 15, 2019
Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring

AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …

News
astrazeneca_building_white

AstraZeneca scores accelerated approval in US and Europe for respiratory syncytial virus drug

February 5, 2019
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, EMA, FDA, MEDI8897, pharma, respiratory syncytial virus

It’s a double victory for AstraZeneca as the company announced its F monoclonal antibody MEDI8897 has been granted accelerated review …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bristol-Myers Squibb, Shire, Takeda, bristol myers squibb, death row, pharma, top 10

With the completion of Takeda’s £46 billion acquisition of Shire finally done, another even bigger merger was announced as US …

News
astrazeneca-sign

AstraZeneca to shut down twin Colorado manufacturing sites, impacting over 200 jobs

January 10, 2019
Manufacturing and Production AstraZeneca, US, job cuts, pharma

UK-based drug firm AstraZeneca has revealed it is set to shed more than 200 positions from its operations at two …

News
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …

Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …

Appointment
astrazeneca_plaque

AstraZeneca loses two senior executives as biotechs appoint new CEOs

January 7, 2019
Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore

Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

News
astrazeneca_sign_sky

NICE recommends AstraZeneca’s Fasenra as third treatment option for severe asthma

January 4, 2019
Medical Communications, Sales and Marketing AstraZeneca, Fasenra, NHS, NICE, UK, asthma, pharma

It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Eli Lilly, Novartis, Teva, Tilray, brexit, celltrion, pharma, top 10

Deals dominated this week as GSK and Pfizer announced that they would combine their consumer healthcare units in a collaboration …

News
astrazeneca_plaque

AstraZeneca scores hat trick in ovarian cancer and anaemia clinical trials

December 20, 2018
Research and Development AstraZeneca, anaemia, oncology, ovarian cancer, pharma

Anglo-Swedish multinational AstraZeneca has revealed that its ovarian cancer drug (Lynparza) and anaemia treatment (Roxadustat) have met their goals in …

News
astrazeneca-sign

China becomes first country to approve roxadustat in chronic kidney disease

December 19, 2018
Research and Development, Sales and Marketing AstraZeneca, China, chronic kidney disease, pharma

AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase inhibitor …

News
shutterstock_273326141

AstraZeneca partners up with CRUK for new UK cancer drug discovery facility

December 10, 2018
Research and Development, Sales and Marketing AstraZeneca, CRUK, Cancer, pharma

AstraZeneca is to team up with Cancer Research UK to build a new centre of excellence for accelerating the discovery …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025